Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bryophyllum Pinnatum for Anxiety in Preterm Birth
NCT05110599Phase 2Terminated
- Start
- Jul 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Bryophyllum pinnatum in anxiety disorder. Started Jul 2022; status: terminated.
02
Drugs
Bryophyllum pinnatum
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT05110599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05110599.